Literature DB >> 19754372

Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals.

Abdus Samad1, Md Intakhab Alam, Kinshuk Saxena.   

Abstract

Dendrimers represent a class of novel polymers having unique molecular architectures characterized by their well-defined structure, with a high degree of molecular uniformity, low polydispersity and properties that make them attractive materials for the development of nanomedicines. The dendrimer drug delivery can be achieved by coupling a drug through one of two approaches. Hydrophobic drugs can be complexed within the hydrophobic dendrimer interior to make them water-soluble or drugs can be covalently coupled onto the surface of the dendrimer. In addition, dendrimers have been shown to be capable of bypassing efflux transporters. A new generation of dendrimer-based delivery systems will enable the efficient transport of drugs across cellular barriers. This review deals principally with the synthesis, characterization and recent applications of dendrimers. In future it will only ever be possible to designate a dendrimer as safe means of drug delivery related to a specific application. However, so far limited clinical experience using dendrimers makes it impossible to designate any particular system which is safe and non toxic. Although there is widespread concern as to the safety of nanosized particles, preclinical and clinical experience gained during the development of polymeric excipients, biomedical polymers and polymer therapeutics showed that judicious development of dendrimer chemistry for each specific application will ensure development of safe and important materials for biomedical and pharmaceutical use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754372     DOI: 10.2174/138161209789058200

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  21 in total

1.  Nanomedicine: action of metal nanoparticles on neuronal nitric oxide synthase-fluorimetric analysis on the mechanism for fibrillogenesis.

Authors:  E R Padayachee; A Arowolo; C G Whiteley
Journal:  Neurochem Res       Date:  2013-11-29       Impact factor: 3.996

Review 2.  Multimodality imaging probes: design and challenges.

Authors:  Angelique Louie
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes.

Authors:  Alex M Chen; Oleh Taratula; Dongguang Wei; Hsin-I Yen; Thresia Thomas; T J Thomas; Tamara Minko; Huixin He
Journal:  ACS Nano       Date:  2010-07-27       Impact factor: 15.881

4.  Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatography.

Authors:  Ankur M Desai; Mark Andreae; Douglas G Mullen; Mark M Banaszak Holl; James R Baker
Journal:  Anal Methods       Date:  2011-01       Impact factor: 2.896

Review 5.  pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.

Authors:  Oleg A Andreev; Donald M Engelman; Yana K Reshetnyak
Journal:  Mol Membr Biol       Date:  2010-10-13       Impact factor: 2.857

6.  Vaults engineered for hydrophobic drug delivery.

Authors:  Daniel C Buehler; Daniel B Toso; Valerie A Kickhoefer; Z Hong Zhou; Leonard H Rome
Journal:  Small       Date:  2011-04-20       Impact factor: 13.281

7.  Toxicology and drug delivery by cucurbit[n]uril type molecular containers.

Authors:  Gaya Hettiarachchi; Duc Nguyen; Jing Wu; Derick Lucas; Da Ma; Lyle Isaacs; Volker Briken
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

8.  mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I:C RNA.

Authors:  Juan Reyes-Reveles; Reza Sedaghat-Herati; David R Gilley; Ashley M Schaeffer; Kartik C Ghosh; Thomas D Greene; Hannah E Gann; Wesley A Dowler; Stephen Kramer; John M Dean; Robert K Delong
Journal:  Biomacromolecules       Date:  2013-10-28       Impact factor: 6.988

9.  Amino-terminated generation 2 poly(amidoamine) dendrimer as a potential broad-spectrum, nonresistance-inducing antibacterial agent.

Authors:  Xiaoyan Xue; Xiaoqing Chen; Xinggang Mao; Zheng Hou; Ying Zhou; Hui Bai; Jingru Meng; Fei Da; Guojun Sang; Yukun Wang; Xiaoxing Luo
Journal:  AAPS J       Date:  2012-11-08       Impact factor: 4.009

10.  PEG-Citrate dendrimer second generation: is this a good carrier for imaging agents In Vitro and In Vivo?

Authors:  Pardis Mohammadzadeh; Mehdi Shafiee Ardestani; Sobhan Mortazavi-Derazkola; Ahmad Bitarafan-Rajabi; Seyedeh Masoumeh Ghoreishi
Journal:  IET Nanobiotechnol       Date:  2019-08       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.